IP Library › Granted Patent US 6,194,406
Granted Patent Utility
US 6,194,406 · App. 09/513,847

Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease

Inventors: John M. Kane, George D. Maynard, Timothy Paul Burkholder, Larry D. Bratton, Christopher R. Dalton, Elizabeth M. Kudlacz, Braulio Santiago
Patented Case View Patent ↗
Granted: Feb 27, 2001 Filed: Oct 29, 1997
Inventors
John M. Kane
George D. Maynard
Timothy Paul Burkholder
Larry D. Bratton
Christopher R. Dalton
Elizabeth M. Kudlacz
Braulio Santiago
Assignee (at issue)
Aventis Pharmaceuticals Inc.

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,194,406
App. No.
09/513,847
Filed
1997-10-29
Granted
2001-02-27
Kind
A